Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would ...
FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new ... a fourth indication for the drug that is also being reviewed by the ...
AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication ... disease and ulcerative colitis look set to be the new battlefields for anti-inflammatory biologics, and ...
Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.
Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.
More clinical trials need to be carried out in order to find new agents as routine treatments for IBD patients. Considering the efficacy, indication and side effects of biological agents ...
Ulcerative colitis in children is often characterized by extensive colitis with a cumulative rate of colectomy up to 40% at 10 years. Scheduled combination therapy with anti-TNF (and pretreatment ...
Intestinal fibrosis, as a late-stage complication of inflammatory bowel disease (IBD), leads to bowel obstruction and requires surgical intervention, significantly lowering the quality of life of ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway ... Crohn's Patients With Advanced Therapy Leads to Dramatic Improvements ...